News Today Logo

Posted 09 Apr 2024

2 min read

  • Report aims to inform outcomes of the 2024 United Nations General Assembly High-level Meeting on AMR, to be held in September 2024. 

 

  • Recommendations for consideration by UNGA meeting on AMR:
    • Convene an Independent Panel on Evidence for Action against Antimicrobial Resistance by 2025, in a One Health context. 
    • Expansion of existing financing instruments such as Green Climate Fund, Global Environment Facility to include AMR.
    • Quadripartite organizations (FAO, UNEP, WHO, WOAH) should urgently update the 2015 Global Action Plan on AMR to ensure One Health response.
    • Report quality assured AMR surveillance data through global surveillance systems (GLASS, ANIMUSE and InFARM).

 

  • Proposed targets (to be achieved by 2030): 
    • Reduction in global deaths caused by bacterial AMR by 10%. 
    • Access group antibiotics comprise at least 80% of overall human antibiotic consumption
      • Access group is one of the groups under WHO AWaRE classification along with Watch and Reserve Groups.
    • Reduce quantity of antimicrobial used in agri-food system globally by at least 30-5-% from current level. 

 

  • GLG on AMR was established in 2020 following the recommendation of the Interagency Coordination Group on AMR (IACG) to advocate for political action for mitigation of drug-resistant infections.

 

Escalating impact of AMR:

  • Leading cause of death globally and will reduce life expectancy globally by 1.8 years by 2035.
  • Compromising food security due to impact on livestock production and global food chain
  • AMR is closely linked to triple planetary crisis of climate, biodiversity loss, and pollution and waste.
  • Greater health expenditures with treatment expenses reaching US$ 412 billion annually up to 2035.
  • Tags :
  • WHO AWaRe
  • UNGA
  • Antimicrobial Resistance
  • Antibiotics
Watch News Today
Width resize handle
Height resize handle

Search Notes

Filter Notes

No notes yet

Create your first note to get started.

No notes found

Try adjusting your search criteria.

Subscribe for Premium Features